Daily Stock List
TheraBiogen, Inc. (TRAB)
OTCPicks and SmallCapVoice reported earlier on TheraBiogen, Inc. (TRAB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
TheraBiogen, Inc. is a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches. The Company makes their products from natural, homeopathic ingredients; the products contain no zinc, which has been identified as potentially causing nasal problems in other similar products on the market. TheraBiogen’s shares trade on the OTC Bulletin Board. Founded in 2000, the Company has their corporate headquarters in New Jersey.
TheraBiogen’s business model is, currently, as a developer and manufacturer of over-the-counter homeopathic pharmaceutical products which aid in the relief of various symptoms and illnesses. They have products for which they have licensed the formulation from a third party. The Company sells those products to the consumer by way of third parties. TheraBiogen’s typical client is a pharmaceutical retail chain or a grocery retail chain.
TheraBiogen is working on adding more products to their Thera Max product line, whether developed internally or acquired or licensed from others. They have developed Thera Max Sore Throat Relief which they plan to introduce to the market this year in addition to the existing Thera Max Cold and Flu relief, Thera Max Allergy Relief and the earlier announced Thera Max Migraine Relief.
TheraBiogen's "Thera Max® Cold and Flu" product is an all-natural, non-zinc, non-addictive, over-the-counter cold and flu relief agent. Thera Max® is available for purchase in over twelve thousand locations including Rite-Aid, Food Lion, Hannaford Supermarkets, Discount Drug Marts and Big Y Supermarkets as well as two of the three largest drug retailers.
The Company has decided to focus their efforts for the near future on marketing directly to the consumer online. They will continue to support their retail outlet customers but not seek any additional programs due to the cost of getting and keeping their products on the retailer's shelves.
In late May of this year, TheraBiogen announced that Mr. Dean Blechman, founding family member and former Executive Vice President of Sales at TWINLAB Corp., agreed to become a consultant to TheraBiogen and assist the Company primarily in Sales & Marketing. As the former Executive Vice President of Sales at TWINLAB, Mr. Blechman was instrumental in growing TWINLAB's annual revenues from $5 million to more than $330 million.
TheraBiogen, Inc. (TRAB), closed on Monday at $0.01, up 1.11%, on 154,000 volume with 5 trades. The average volume for the last 60 days is 27,321. The 52-week low/high is $0.005/$0.08.
Biomerica, Inc. (BMRA)
Today we are highlighting Biomerica, Inc. (BMRA), here at the QualityStocks Daily Newsletter.
Biomerica, Inc. is a global biomedical company with corporate headquarters in Irvine, California. The Company develops, manufactures and markets advanced diagnostic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for the early detection of medical conditions and diseases. Biomerica’s shares trade on the OTC Bulletin Board.
The Company’s main facility occupies an area of more than 23,000 square feet in Irvine. This complex houses their headquarters, including administrative offices, laboratories, and FDA registered manufacturing facilities. Biomerica also operates a 10,000 square foot production facility in Mexicali, Mexico. As is the U.S. headquarters, the Mexico facility is both EN ISO 13485 and FDA certified. All of the Company’s products are CE marked for European sales.
Biomerica primarily focuses on products for Diabetes, Gastrointestinal Disease and esoteric testing. They were the first Company to manufacture and market tests for Myoglobin (Cardiac); H. Pylori (Digestive Disease); Histamine (Allergy); a self test for Colon Disease (Digestive), and early detection of Diabetes (Diabetes).
In March of this year, Biomerica announced that they introduced two new E. coli tests for detecting verotoxin and E. coli 0157. The Company has developed E. coli O157 which allows for the rapid determination of E. coli 0157, and Verotoxin which detects both verotoxin 1 and verotoxin 2. Biomerica's E. coli Verotoxin and 0157 products are FDA exempt in the United States and will also sell worldwide.
In April 2012, Biomerica reported net income for the nine months ended February 29, 2012 of $494,329 compared to a net income of $61,354 during the same period in fiscal 2011. For the quarter ended February 29, 2012 they reported a net income of $181,445 compared to net income of $73,403 for the same period in the previous fiscal year.
Biomerica announced net sales of $4,538,944 for the first nine months of fiscal 2012 compared to net sales of $3,684,454 for the first nine months in fiscal 2011. Net sales were $1,514,673 for the third quarter of fiscal 2012 ended February 29, 2012, compared to net sales of $1,345,900 in fiscal 2011.
Biomerica, Inc. (BMRA), closed on Monday at $0.75, up 7.14%, on 5,068 volume with 3 trades. The average volume for the last 60 days is 2,571. The 52-week low/high is $0.38/$0.89.
Lapolla Industries, Inc. (LPAD)
MoneyTV and FeedBlitz reported previously on Lapolla Industries, Inc. (LPAD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Lapolla Industries, Inc. engages in the manufacture and distribution of foam and coatings used in commercial, industrial, and residential applications in the insulation and construction industries in the United States and Canada. The Company’s customers are spray applicators that promote and install better building solutions. Lapolla sells their products directly, as well as through independent representatives, distributors, and public bonded warehouses. Lapolla Industries lists on the OTC Bulletin Board. Incorporated in 1989, the Company is based in Houston, Texas.
The Company’s Foam segment is involved in supplying spray foam insulation and roofing foam to the construction industry. The spray foam insulation applications consist of perimeter wall, crawl space, and attic space applications. The roofing applications include new and retrofit applications. This segment also supplies polyurethane as an adhesive for board stock insulation to roofing substrates; sundry items; and application equipment.
Their Coatings segment supplies various protective coatings for roofing systems for new and retrofit applications to the roofing industry. This segment also supplies caulking for general application in the construction industry; and sundry items.
Lapolla Industries’ products primarily address the growing consumer awareness of the building envelope. The physical components of the envelope include the foundation, roof, walls, doors and windows. A building envelope is the separation between the interior and the exterior environments of a building. It serves as the outer shell to protect the indoor environment and to facilitate its climate control. The Company provides insulation, an air barrier, and a vapor barrier with their products.
In May, Lapolla Industries announced results for the first quarter of 2012. Sales increased $677,397, or 3.8 percent, for the first quarter of 2012 compared to the first quarter of 2011. Gross profit decreased $246,940, or 6.5 percent, for the first quarter of 2012 compared to the first quarter of 2011. Gross margin percentage decreased 2.1 percent, quarter over quarter. Net loss increased $421,590, or 94.0 percent, in the first quarter of 2012 compared to the first quarter of 2011. Net loss per share was $0.01 for the quarter ended March 31, 2012 and 2011, respectively.
Lapolla Industries, Inc. (LPAD), closed on Monday at $0.17, down 22.73%, on 18,685 volume with 8 trades. The average volume for the last 60 days is 6,422. The 52-week low/high is $0.20/$0.76.
Superconductor Technologies, Inc. (SCON)
SmarTrend Newsletters reported earlier on Superconductor Technologies, Inc. (SCON), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Superconductor Technologies, Inc. is a world leader in the development and production of high temperature superconducting (HTS) materials and associated technologies. The Company has been a global leader in HTS materials since 1987, developing over 100 patents as well as proprietary trade secrets and manufacturing expertise. Superconductor Technologies has their headquarters in Austin, Texas. The Company’s shares trade on the NASDAQ Capital Market.
Superconductor Technologies provides innovative interference elimination and network enhancement solutions to the commercial wireless industry. Currently, the Company is taking advantage of their key enabling technologies, including RF filtering, HTS materials and cryogenics to develop energy efficient, cost-effective and high performance second generation (2G) HTS wire for existing and emerging power applications, to develop applications for advanced RF wireless solutions and innovative adaptive filtering, and for government R&D.
Superconductor Technologies is the world’s only commercialized, high-throughput HTS thin film materials developer for RF applications. The Company has deployed more than 6,000 HTS filter systems operating today in public wireless networks. Presently, the Company is applying their unique deposition techniques and manufacturing experience to the development of cost effective, high performance 2G HTS wire for applications ranging from AC Power Cables to Superconducting Fault Current Limiters (SFCL) and HTS Wind Turbine Generators.
Concerning Wireless, the Company’s flagship product, SuperLink®, combines a specialized filter using patented high-temperature superconductor (HTS) technology with a proprietary cryogenic cooler and a low-noise amplifier. The result is a highly compact and reliable cryogenic receiver front-end (CRFE) that simultaneously delivers high selectivity and high sensitivity. With Superconductor Technologies’ SuperLink®, AmpLink™ and SuperPlex® product lines, wireless operators can maximize capacity utilization and coverage, and provide high performance antenna sharing solutions.
Recently, Superconductor Technologies announced that they intend to release their second quarter 2012 financial results before the market opens on Thursday, August 9, 2012. The Company will host a conference call and simultaneous webcast that same day at 11:00 a.m. Eastern Time/8:00 a.m. Pacific Time to discuss their results. Participating in the call will be Mr. Jeff Quiram, President and Chief Executive Officer; and Mr. Bill Buchanan, Vice President and Chief Financial Officer.
Superconductor Technologies, Inc. (SCON), closed on Monday at $0.75, down 2.36%, on 32,337 volume with 47 trades. The average volume for the last 60 days is 73,666. The 52-week low/high is $0.60/$2.19.
Today’s Alternative Energy Corporation (TAEC)
CrushTheStreet.com reported today on Today’s Alternative Energy Corporation (TAEC), OtcWizard, Nebula Stocks, PennyStockScholar, OTCtipReporter, Wise Penny Stocks did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCBB, Today’s Alternative Energy Corporation is a "Green Company" with headquarters in Fairfield, Connecticut. The Company engages in the exportation, development and integration of green non-fossil fuel energy alternatives. Research, design and fuel efficiencies requirements are also implemented in the development and introduction of Green products for public and industry use.
Pertaining to the Company’s Cleaning Division, Today’s Alternative Energy, as a public enterprise, has spent ten years developing microbe remediation solutions and services that can digest “brown” grease safely and without “downstream” congealing in the sewer lines. The Company has created several “menu specific” proprietary formulations that eliminate organic waste and odors at food service facilities.
As concerns their Bio Diesel Division, the Company’s laboratory trials have been completed to convert liquid brown trap grease (LBTG) into B100 bio-diesel fuel, using a combination of patent pending bio-extractors, proprietary pre-screening methods and trade secret remediation formulations. Their laboratory trials have included additives that address the problems of cold starts and jelling, improved performance and lowered emissions of noxious nitrous oxide emissions.
On Saturday, the Company announced the appointment of Mr. Albertus Hendrik van Leiden to the role of Chief Executive Officer. Mr. van Leiden brings to Todays Alternative Energy more than 40 years of expansive and diverse experience in the energy field. Mr. van Leiden was the founder and has been the Chief Executive Officer of ProOne Europe B.V. since 2010. ProOne Europe B.V. is headquartered in the Netherlands and specializes in the sale and distribution of cost-effective and environmentally friendly lubrication and cutting fluids.
Yesterday, Today’s Alternative Energy formally announced their entry into the solar energy industry with the establishment of the Company’s new Solar division. Mr. van Laiden said that "We have been watching closely the developments in solar technology for a while now. Solar technology and the exploration of Solar, as an alternative non fossil fuel, green energy source fits perfectly into the footprint of what Today’s Alternative Energy, TAEC, is doing as a company.
Today’s Alternative Energy Corporation (TAEC), closed on Monday at $0.10, down 9.095, on 3,677,724 volume with 651 trades. The average volume for the last 60 days is 40,204. The 52-week low/high is $0.01/$0.46.
Murgor Resources, Inc. (MGR.V)
Today we are reporting on Murgor Resources, Inc. (MGR.V), here at the QualityStocks Daily Newsletter.
Murgor Resources, Inc. is a mineral exploration and development Company whose shares trade on the TSX Venture Exchange. The Company focuses on gold and copper exploration in Canada. They also have exposure to zinc and silver as significant bi-products contained in their deposits. Murgor Resources has their headquarters in Kingston, Ontario, and an exploration office in Porcupine, Ontario.
Murgor explores in the most prolific and mining-friendly jurisdictions of the world. These include the Timmins and Red Lake Gold Districts of Ontario, the Chibougamau Gold-Copper Mining District in Quebec and the Flin Flon Belt of Manitoba.
The Company concentrates on near-term production at the Golden Arrow Gold Mine in Ontario. Murgor also owns a 100 percent interest in two gold-copper deposits in the Snow Lake and Flin Flon mining districts of Manitoba. In addition, Murgor further owns a portfolio of gold properties in proven mining districts of Canada, as well as a 1 percent NSR royalty in the Barry Gold Mine and the Windfall Gold Project in Quebec.
Since acquiring the Golden Arrow property in 2011, Murgor Resources has expanded the property to include 20 mining patents and leases and 11 mining claims covering over 1,377 hectares located just south of the town of Matheson and 65 kilometers east of the town of Timmins in Ontario. The Company continues their extensive drilling of the Golden Arrow Main Zone to better define and increase the gold resource already outlined and to evaluate the economic potential of the deposit. Simultaneously, Murgor is exploring the largely untested property to test high-priority exploration targets and to outline new mineralized zones.
On June 7, 2012, Northern Superior Resources, Inc. (SUP.V) announced that they signed an option agreement with Murgor Resources, granting Northern Superior an option to acquire 70 percent of Murgor's Waconichi gold property. This gold property consists of 316 mineral claims, or approximately 17,226 hectares, located 10 kilometers northwest of Chibougamau, Quebec. Northern Superior has the option to earn the 70 percent interest in the Waconichi gold project by meeting certain obligations. Northern Superior retains the right to accelerate any of the obligations. Northern Superior is a junior exploration company focusing on exploring for gold in the Superior Province of the Canadian Shield.
The two companies have agreed that any further claims staked within 1.5 km of the property (excluding any claims which currently form part of the Croteau Est property), shall form part of the option. They have agreed to execute and deliver a definitive joint venture agreement no later than 90 days after the signing of the option agreement.
Murgor Resources, Inc. (MGR.V), closed on Monday at $0.05, up 11.11%, on 573,000 volume.
IC Potash Corp. (ICP.TO)
Today we are reporting on IC Potash Corp. (ICP.TO), here at the QualityStocks Daily Newsletter.
IC Potash Corp.’s intention is to become a primary producer of Sulphate of Potash (SOP) and Sulphate of Potash Magnesia (SOPM) by mining their 100 percent-owned Polyhalite Ochoa property in New Mexico. This is a highly advanced mineral deposit containing proven and probable reserves of more than 340 million tons of ore within the proposed mine plan. The Company’s Ochoa property consists of more than 100,000 acres of federal subsurface potassium prospecting permits and State of New Mexico potassium mining leases. IC Potash lists on the Toronto Stock Exchange and on the OTCQX International (ICPTF).
SOP is a non-chloride based potash fertilizer. It sells at a substantial premium over the price of regular potash known as Muriate of Potash (MOP). MOP contains chloride; it is not the optimal potash for numerous crops and in situations where there is high soil salinity. The SOP market is almost six million tonnes annually. SOP is a significant fertilizer in the fruit, vegetable, tobacco, potato, and horticultural industries. It is also applicable in soils where there is substantial agricultural activity with varieties of crops. SOPM is a highly desirable potash product for soils with magnesium deficiency. This includes those found in Europe and Southeast Asia. SOPM has a total worldwide market size of more than one million tonnes.
In July, IC Potash announced that they completed their two deep groundwater production wells which will be used to supply water to the Company’s Ochoa Sulphate of Potash Project in Lea County of southeast New Mexico. In addition, they began pumping tests at full planned capacity to demonstrate to the New Mexico Office of the State Engineer and to the Bureau of Land Management that the hydraulic properties of the water being drawn from the Capitan Reef satisfy regulatory requirements. The data generated by the pumping tests will be used to support the planned water use. The final regulatory assessment of the water supply and the proposed pumping will undergo evaluation by the Bureau of Land Management and the New Mexico Office of the State Engineer for final permitting purposes.
Recently, IC Potash announced the appointment of Arthur J. Roth as Director of Marketing. Mr. Roth is a globally respected industry veteran with over 50 years of experience in domestic and international marketing, transportation, and distribution of fertilizer products. Reporting directly to Sidney Himmel, President and CEO of IC Potash, Mr. Roth will be responsible for formulating marketing plans and distribution strategies, establishing and negotiating commercial relationships, and coordinating with IC Potash partners and fertilizer industry groups.
IC Potash Corp. (ICP.TO), closed on Monday at $0.93, up 5.68%, on 58,143 volume. The 52-week low/high is $0.67/$1.31.
Baltia Air Lines, Inc. (BLTA)
MicrocapVoice and THEOTCBBLIST reported previously on Baltia Air Lines, Inc. (BLTA), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Baltia Air Lines, Inc. is a development stage company that lists on the OTC Bulletin Board. The Company intends to offer scheduled passenger, cargo, and mail transportation services. Baltia focuses on providing their services from the U.S. to the Russian Federation, as well as to the former Soviet Union countries. Baltia Air Lines is based in Jamaica, New York, at John F. Kennedy International Airport.
On December 19, 2008, the U.S. Department of Transportation (DOT) issued their Order to Show Cause, finding that Baltia Air Lines is fit, willing and able to engage in international air transport of persons, property and mail. The Company was awarded the non-stop route from JFK to St. Petersburg, Russia. There is currently no non-stop service from JFK to St. Petersburg. Baltia was also authorized for worldwide charter services.
The Company is the only Part 121 (heavy jet operator) start-up airline in the United States today that has received Government fitness approval. Baltia is currently conducting the FAA Air Carrier Certification. On August 18, 2009, the Company purchased a Boeing 747 aircraft (N705BL). In 2010, Baltia purchased a second Boeing 747 aircraft (N706BL). Baltia leases engines on a power-by-the-hour basis, which are installed on the aircraft. On January 11, 2012, Baltia sold Boeing 747 aircraft (N705BL).
Following the beginning of service on the JFK-St. Petersburg route, Baltia Air Line's objective is to develop their route network to Russia, Latvia, Ukraine, and Belarus. Baltia has two registered trademarks "BALTIA" and "VOYAGER CLASS"; five trademarks are subject to registration.
Baltia Air Line’s corporate objective is to establish the Company as the leading non-stop carrier in the market niche over the North Atlantic with operations that are profitable and growing over time. Baltia does not expect to be in direct competition with deep discount airlines. These include a number of East European airlines and the offspring of the former Soviet airline Aeroflot, which provide connecting flights.
The Company’s intention is to provide First, Business, and Voyager Class accommodations. The tailoring of their passenger market strategy is to particular preferences of the various segments of their customer base, with marketing attention specifically focusing on American business travelers with interests in Russia who require high quality, non-stop service from the United States to Russia.
Baltia intends to provide customer service and reservations centers in New York and in St. Petersburg, to list Baltia's schedules and tariffs in the Official Airline Guide, and provide worldwide access to reservations on Baltia's flights via a major Computer Reservations and Ticketing System (CRS). The Company intends to activate their reservations service when the DOT issues their order authorizing Baltia Air Lines to sell tickets.
Baltia Air Lines, Inc. (BLTA), closed on Monday at $0.02, down 15.22%, on 2,651,579 volume with 45 trades. The average volume for the last 60 days is 6,936. The 52-week low/high is $0.01/$0.06.
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.31, even for the day, on 52,250 volume with 19 trades. The stock’s average daily volume over the past 60 days is 11,456, and its 52-week low/high is $0.21/$1.00.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation's Co-Chairman and CEO Andrey Semechkin PhD Publishes Letter to Shareholders
International Stem Cell Corporation Featured in Stem Cell Technology's Bright Future Article on Seeking Alpha
International Stem Cell Corporation Reports Reaching Milestone in Its Cornea Program
Duma Energy Corp. (DUMA)
The QualityStocks Daily Newsletter would like to spotlight Duma Energy Corp. (DUMA). Today, Duma Energy Corp. closed trading at $1.51, even for the day, on 950 volume with 3 trades. The stock’s average daily volume over the past 60 days is 6,217, and its 52-week low/high is $1.10/$4.00.
Duma Energy Corp. (DUMA) is an aggressive growth company actively producing oil and gas in the domestic United States, both on and offshore. Leveraging its technical expertise, promising portfolio, and strong financial condition, the company plans to utilize domestic revenues and cash flow to fund its rapid growth through acquisition, while participating in transformational projects with the potential of providing exponential returns for shareholders.
The company's primary goal for fiscal year 2012 and beyond is to drive earnings growth. The company also aims to pursue listing on major exchange(s) to provide better visibility and liquidity to shareholders and financial partners. Already producing and generating revenue from oil and gas in Texas, Illinois, and Louisiana, Duma projects domestic production to exceed 1,000 barrels of oil equivalent per day (boepd) by the end of 2012; with 2,500 boepd projected by the end of 2013.
Duma was founded in 2005 and began trading on the OTCBB in 2009 via registration. In 2006, the company began producing from its first properties in Texas and soon after added production in Louisiana. In 2009, its new CEO Jeremy G. Driver came on board. Within one year, Mr. Driver had identified and negotiated an acquisition that would fundamentally reshape the company. This acquisition was made possible by the large direct cash investment by Mr. Driver and his family, as well as other investors.
The company uses only industry standard and time-tested technologies, and avoids unproven "resource plays" and other opportunities that are heavily dependent upon high commodity prices. Not bound by any geographical location or operational strategy, Duma's management team is focused on developing its existing portfolio while pursuing additional opportunities that provide rapid growth, leveraging growing revenue, cash flow, and reserves to accelerate its growth strategy. Disclaimer
Duma Energy Corp. Company Blog
Duma Energy Corp. News:
Duma Energy Enters Final Stage of Negotiations for African Concession
Duma Energy Provides Third Quarter Results and Demonstrates Positive Earnings
Duma Energy Announces New Trading Symbol "DUMA"
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.75, even with yesterday's close, on 2,100 volume with 5 trades. The stock’s average daily volume over the past 60 days is 3,462, and its 52-week low/high is $1.02/$1.87.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Announces New Channel Sales Partnership With RJ Young
GlobalWise Accepted as Member of Prestigious Organization Technology United
GlobalWise CEO to Be Featured Speaker at World Expo 2012 Conference
USA Recycling Industries, Inc. (USRI)
The QualityStocks Daily Newsletter would like to spotlight USA Recycling Industries, Inc. (USRI). Today, USA Recycling Industries, Inc. closed trading at $0.08, even with yesterday's close, on 10,800 volume with 3 trades. The stock’s average daily volume over the past 60 days is 15,859, and its 52-week low/high is $0.03/$0.14.
USA Recycling Industries, Inc. (USRI) is a mid-market recyclable waste collection & disposal service, providing specialty recycling programs to commercial & industrial customers throughout North America. Operating through multiple company-owned & partnership recycling centers, the company primarily targets growth opportunities in the $75 billion global scrap metals market.
USA Recycling has operated since its inception in 2000, and its largest operating subsidiary, Scrap USA, since 2007 has been focused on and successful in servicing the automotive service center industry. It currently provides specialty recycling programs to more than 5,000 automotive service center locations operated by some of the most recognizable names in that retail category.
With a well-established national footprint, the company is now integrating other ancillary services such as the collection & disposal of other recyclable waste streams. USA Recycling has also opened the door to franchising opportunities and recently signed a proprietary revenue sharing agreement with Recycling Franchisors, Inc. Other initiatives to drive growth and boost prominence include the launch of a new website and relocation of executive offices.
USA Recycling has successfully contracted automotive waste-generators for collection & disposal services, selling the processed recyclable materials to end-user-consumers through the company's trading operations with offices in North America, India, and the United Arab Emirates. The company's primary aim is to maximize shareholder value while providing the highest level of quality waste collection & disposal services to its customers, ensuring its collected debris remain free of any U.S. landfills. Disclaimer
USA Recycling Industries, Inc. Company Blog
USA Recycling Industries, Inc. News:
USA Recycling Industries to Provide Scrap Metal Collection Services to ThyssenKrupp Elevator Americas
USA Recycling Industries Enters Oil Filter Collection and Disposal Services Agreement With Redwood Recycling
USA Recycling Industries Signs Letter of Intent to Expand Used Oil Filter Recycling Operations
Recently, the CEO of International Stem Cell Corp., Andrey Semechkin, PhD, issued a shareholder letter discussing some of the key developments that have occurred in the company, and providing a window on future plans and anticipated events. ISCO is a California based biotechnology company with a powerful new stem cell technology called parthenogenesis, which promises to deliver stem cells that address the critical problem of immune-rejection.
In addition to talking about certain management adjustments, the letter discusses a number of operational changes designed to improve efficiency and target the company’s resources to the most productive ends.
The company has moved its accounting department from Maryland to California, site of the company’s headquarters, allowing them to streamline various accounting processes. The company has also implemented the necessary controls and processes for compliance with SOX (Sarbanes–Oxley Act of 2002), the federal law that sets new or enhanced standards for all U.S. public company boards.
The letter goes on to say that the company has made significant progress in perfecting differentiation technology for their three main areas of focus: Parkinson’s disease, endoderm, and cornea programs, with their scientific team developing new methods to derive high-purity populations of cell types important for the therapeutic use of ISCO’s parthenogenetic stem cells.
The company’s one-of-a-kind stem cell bank currently contains ten parthenogenetic stem cell lines which were originally derived in Moscow, Russia. These lines are capable of immune-matching approximately 70 million people worldwide. Such banking is important not only because the cells represent a source of cells for the company’s therapeutic programs, but also because licensing the cell lines may produce a revenue stream in the future.
ISCO’s Lifeline Skin Care brand of stem cell based skin rejuvenation applications continues to grow. The company has expanded to a multi-channel model with many strategic partners. Lifeline Skin Care will soon be launching new sales and marketing campaigns in magazines, online, and through direct mail. The company believes it can leverage their unique technology to become a leader in the premium branded skin care market.
Sales for Lifeline Cell Technology, an ISCO company that produces and markets specialized cells and growth media for therapeutic research worldwide, also continue to grow, with 2011 showing a 40% revenue increase over 2010.
The shareholder letter, in its entirety, can be found at the following link: www.InternationalStemCell.com/2012_Shareholder_Letter.
For additional information, visit the company’s website at www.InternationalStemCell.com
Duma Energy is an aggressive growth company actively producing oil and gas in the U.S., both on and offshore. The company currently has major operations in Texas, with additional operational interests in Illinois and Louisiana. Duma plans to continue increasing its revenue, cash flow, and reserves to fund its growth through acquisition and participation in projects with the potential of providing exponential returns for shareholders. Specifically, the company plans to do the following:
• Seek additional acquisitions
• Consider international projects with unique opportunities for high returns
• Leverage growing revenue, cash flow, and reserves, to fund overall growth strategy
Besides its Texas projects, Duma’s geologists and engineers identified and developed the Markham City North project in Illinois, and subsequently marketed it to potential operators and financial partners with experience in the Illinois Basin. Core Minerals eventually accepted the role of operator, with a $1.35 million investment. The field is currently undergoing pilot waterflood testing. Duma also owns passive royalty in 2 fields in Louisiana, operated by ETG Energy (Tradestar), producing oil, with no significant gas.
In addition to domestic operations, Duma is pursuing acquisition of a private company with significant interests in an African concession totaling approximately 6 million acres.
The success of Duma’s aggressive yet careful approach, focusing on proven sites and technologies, is seen in their production numbers. The company expects to be producing at least 1,000 boe per day gross by the end of 2012, and 2,500 boe per day by the end of 2013.
For additional information, visit the company’s website at www.DUMA.com
Asia Entertainment & Resources Ltd. is a holding company which operates through its subsidiaries and related promotion companies as a VIP room gaming promoter, receiving revenues from such activities. The company’s VIP room gaming promoters currently participate in the promotion of three major luxury VIP gaming facilities in Macao, the largest gaming market in the world. The three facilities are located at the Star World Hotel & Casino, the Galaxy Macau resort in Cotai and the Venetian Macao Resort Hotel, also in Cotai.
The company announced today that it has entered into a non-binding memorandum of understanding to acquire Bao Li Gaming Promotion Limited, a Macao-based VIP gaming promoter that currently operates one room with five tables at City of Dreams Macau, a Melco Crown property. This casino offers both the fixed commission and the revenue sharing remuneration model, and this VIP room will operate under the revenue sharing model.
Subject to due diligence and the customary closing conditions, Asia Entertainment expects to close the transaction by September 30, 2012. Asia Entertainment is expected to pay approximately $15 million for 100 percent of Bao Li Gaming’s operations. Additionally, if its ‘rolling chip turnover’ is at least $2.5 billion in each of the three years ending December 31, 2013, 2014 and 2015, its shareholders would receive three additional installments of $13 million and 625,000 ordinary shares of AERL. The shareholders can also receive additional incentives if those targets are exceeded.
This proposed deal is an important one for Asia Entertainment. In addition to its presence in the Galaxy and Las Vegas Sands casinos, it now will have a presence with another gaming license holder (Melco Crown). Upon completion of the deal, Asia Entertainment will have 34 tables in four VIP rooms.
For further information about Asia Entertainment & Resources and its gaming activities in Macao, please visit the company’s website at http://ir.aerlf.com/index.cfm
Today, Insmed Incorporated announced that Al Altomari has been elected to its Board of Directors, effective immediately. Including Mr. Altomari, Insmed’s Board of Directors now consists of seven members.
Donald j. Hayden, Insmed’s Executive Chairman, remarked, “Al brings to our Board nearly 30 years of valuable experience in the pharmaceutical industry, including more than 20 years focused on the development and marketing of specialty pharmaceutical products. We believe his expertise in these areas will be instrumental as we continue to execute on our development plan for ARIKACE®.”
Mr. Altomari added, “With top-line data for ARIKACE in the Company’s lead orphan indications, cystic fibrosis-related Pseudomonas lung infections, and non-TB Mycobacteria lung infections expected in 2013, this is an exciting time to be joining Insmed’s Board. I look forward to lending my specialty pharmaceutical development and marketing expertise to the Company’s Board and management team.”
Since October 2010, Mr. Altomari has served as President and Chief Executive Officer and board member at Agile Therapeutics, a privately held pharmaceutical company. Prior to being named President and CEO, he served as Agile’s Executive Chairman, during which time he closed a $45 million investment round in May 2010.
Prior to Agile, Mr. Altomari spent five years in multiple senior management positions at Barrier Therapeutics. He was directly responsible for placing the company’s commercial infrastructure and all sales and marketing functions for Barrier’s product portfolio; he also oversaw management of all worldwide business development initiatives. In 2008, as its CEO and member of the company’s Board of Directors, Mr. Altomari successfully completed the sale of the company to GlaxoSmithKline/Stiefel Laboratories.
From 1982-2003, Mr. Altomari held numerous executive roles in general management, commercial operations, business development, product launch preparation, and finance with Johnson & Johnson, where he successfully led the integration of Ortho Dermatological and Neutrogena Professional. Mr. Altomari also served as Vice President/Franchise Head of Ortho-McNeil Pharmaceutical’s Women’s Health Care Franchise, where he introduced several life cycle and new product development initiatives, including the launch of the contraceptive patch, ORTHO Evra™.
In July 2007, PharmaVoice Magazine recognized Mr. Altomari as one of its Top 100 Most Inspirational and Influential leaders in the Life Sciences Industry. He holds a Masters in Business Administration from Rider University and a Bachelor of Science from Drexel University. Mr. Altomari also serves on the advisory board for Le Bow College, Drexel University’s business school.
Today's Top 3
The QualityStocks Public Company Sponsor News